“Efficacy of Kutaki in the Management of Dyslipidemia-A Randomized Control Trial”
DOI:
https://doi.org/10.61841/ptpkjq52Keywords:
Atorvastatin, Ama, Dyslipidemia, Medoroga, KutakiAbstract
Dyslipidemia is the disorder of lipoprotein metabolism manifested by elevation of the total cholesterol, the low density lipoprotein (LDL) cholesterol and the triglyceride concentrations and a decrease in the high density lipoprotein (HDL) cholesterol concentration in the blood. In Ayurveda, direct reference of Dyslipidemia is not found but it can be correlated with Medodushti and can be included under Santarpanjanya Vyadhi as “Medoroga”. Agni is responsible for all metabolic processes in the body. Decreased Agni leads to “Ama” (undigested/partially digested food) production, which is the main cause of all diseases. To study the efficacy of Kutaki in the management of Dyslipidemia and to compare the effects of Kutaki and Atorvastatin on BMI, serum lipid levels, AST, ALT, serum creatinine and serum urea. In this study,160 patients will be divided randomly into 2 groups (80 in each ).In Group A (Experimental) – Kutaki vati 500 mg will be administered twice a day with water before meal for 60 days and Group B (Control) – Atorvastatin10 mg will be administered at bed time for 60 days.Assessement will be recorded on 0 and 60th day. Changes will be observed in objective outcomes. Kutaki vati will be more effective than Tab. Atorvastatin.
Downloads
References
1. API Textbook of Medicine, 10th Edition, Jaypee Brothers Medical publishers, Published 2015 ; pp: 2872; pg.1690
2. Davis CE, Rifkind BM, Brenner H, et al. A single cholesterol measurement underestimates the risk of coronary heart disease. An empirical example from the lipid research clinics mortality follow-up study. JAMA. 1990;264(23):3044– 3046. [PubMed] [Cross Ref]
3. Seema Gulati,Anoop Mishra, Effects of 3 g of soluble fiber from oats on lipid levels of Asian Indians - a randomized controlled, parallel arm study Lipids Health Dis. 2017; 16: 71
4. WHO, Cardiovascular Disease,‖ Fact sheet no. 317, WHO, Geneva, Switzerland, 2009, www.who.int/mediacentre/factsheets/fs317/en/print.html.
5. Madhavakara, Madhava Nidana with Madhukosha commentary of Vijaya rakshita and Shrikantadatta, Medoroga Nidanam, published by Varanaseya Sanskrit Samsthana; Varanasi. 1993. Pg.No 28.
6. Agnivesha, Charaka Samhita, Revised by Charaka and Drdhabala, Ayurveda Dipika Commentry of Chakrapani Datta,Edited by Vaidya Jadavji Trikamji Acharya, Chowkhamba Krishnadas Academy Varanasi, Reprint2010,suthrasthana, Chapter- 21, pp- 738,pg116.
7. Harrison TR. Harrison’s Principles of Internal Medicines, 19th International Edition. In: Braunwald E, Fanci AS,Hauser SL, Kasper DL, Longo DL, Jameson JL (editors).,New York: McGraw-Hill Medical Publishing Division,Vol. II, pg no. (2447)
8. Bhavamisra: Bhavprakasa Nighantu.Edited by Pandey G S. Chaukhambha Bharati Academy, Varanasi. 2004; 152/70.
9. Lee HS, Yoo CB, Ku SK (2006):Hypolipemic effect of water extracts of Picrorhiza kurroa in high fat diet treated mouse. Fitoterapia. 2006; 77(7-8): 57984.
10. Sharma PV, Dravyaguna Vijnana,vol 2,reprint,Varanasi, Chaukhambha Bharati academy; 1999; p.441)
11. Anonymous. ‘Database on Medicinal Plants Used on Ayurveda’. Vol.7 p.179206.
12. Tripathi K. D. (1994). ‘Essentials of Medical Pharmacology’, Jaypee Brother´s Medical Publishers, New Dehli, 3 ed., pp-235.
13. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143– 421.)
14. Phadnis P, Kamble MA, Daigavane S, Tidke P, Gautam S. Prevalence and risk factors – Hemoglobin A1c, serum magnesium, lipids, and microalbuminuria for diabetic retinopathy: A rural hospital-based study. J Datta Meghe Inst Med Sci Univ 2017;12(2):121-132.
15. Yadav S, Agrawal M, Hariharan C, Dewani D, Vadera K, Krishna N. A comparative study of serum lipid profile of women with preeclampsia and normotensive pregnancy. J Datta Meghe Inst Med Sci Univ 2018;13(2):83-86.
16. Acharya S, Shukla S. Metabolic healthy obesity-a paradoxical fallacy? J Clin Diagn Res 2018;12(10):OE07-OE10.
17. Bhinder HHPS, Kamble TK. The study of carotid intima-media thickness in prediabetes and its correlation with cardiovascular risk factors. J Datta Meghe Inst Med Sci Univ 2018;13(2):79-82.
18. Papalkar, P., S. Kumar, S. Agrawal, N. Raisinghani, G. Marfani, and A. Mishra. “Heterotaxy Syndrome Presenting as Severe Pulmonary Artery Hypertension in a Young Old Female: Case Report.” Journal of Gerontology and Geriatrics 66, no. 2 (2018): 59–61.
19. Charan, N., M. Choudhari, M. Sonkusale, and R. Deshpande. “Anesthetic Management of Chronic Thromboembolic Pulmonary Hypertension for Pulmonary Endarterectomy.” Journal of Datta Meghe Institute of Medical Sciences University 12, no. 4 (2017): 289–91. https://doi.org/10.4103/jdmimsu.jdmimsu_40_17.
20. Gaikwad, K.B., N.G. Joshi, and S.P. Selkar. “Study of Nitrosative Stress in ‘Pregnancy Induced Hypertension.’” Journal of Clinical and Diagnostic Research 11, no. 3 (2017): BC06–8. https://doi.org/10.7860/JCDR/2017/23960.9396.
21. Kumar, S., P. Bhayani, D. Hathi, and J. Bhagwati. “Hyponatremia Initial Presenting Feature of Normal Pressure Hydrocephalus in Elderly Patient: A Rare Case Report.” Journal of Gerontology and Geriatrics 66, no. 3 (2018): 156–57.
22. Khatib, M.N., R. Kirubakaran, S. Gaidhane, A.H. Shankar, and Z. Quazi Syed. “Yoga for Improving Functional Capacity, Quality of Life and Cardiovascular Outcomes in People with Heart Failure.” Cochrane Database of Systematic Reviews 2017, no. 7 (2017). https://doi.org/10.1002/14651858.CD012015.pub2.
23. Rathi, N., B. Taksande, and S. Kumar. “Nerve Conduction Studies of Peripheral Motor and Sensory Nerves in the Subjects with Prediabetes.” Journal of Endocrinology and Metabolism 9, no. 5 (2019): 147–50. https://doi.org/10.14740/jem602.
24. Walinjkar, R.S., S. Khadse, S. Kumar, S. Bawankule, and S. Acharya. “Platelet Indices as a Predictor of Microvascular Complications in Type 2 Diabetes.” Indian Journal of Endocrinology and Metabolism 23, no. 2 (2019): 206–10. https://doi.org/10.4103/ijem.IJEM-13-19.
25. Dande, R., A.R. Gadbail, S. Sarode, M.P.M. Gadbail, S.M. Gondivkar, M. Gawande, S.C. Sarode, G.S. Sarode, and S. Patil. “Oral Manifestations in Diabetic and Nondiabetic Chronic Renal Failure Patients Receiving Hemodialysis.” Journal of Contemporary Dental Practice 19, no. 4 (2018): 398–403. https://doi.org/10.5005/jp-journals-10024-2273.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
